Zobrazeno 1 - 8
of 8
pro vyhledávání: '"A. Costa Valarezo"'
Publikováno v:
Neurology Perspectives, Vol 4, Iss , Pp 239- (2024)
Externí odkaz:
https://doaj.org/article/935af303e3144e6a9d854481a378b481
Publikováno v:
Neurology Perspectives, Vol 4, Iss , Pp 255- (2024)
Externí odkaz:
https://doaj.org/article/e0a8a7f27246409f8837b1827ce58cee
Publikováno v:
In Reumatología clínica (English Edition) July-August 2016 12(4):210-215
Publikováno v:
In Reumatologia Clinica July-August 2016 12(4):210-215
Autor:
Costa Valarezo, A., Ruiz Giménez, J., Olivares Granados, G., Ortega León, T., Medina Martínez, I.
Publikováno v:
In Neurology Perspectives November 2024 4 Supplement 1:255-255
Publikováno v:
In Neurology Perspectives November 2024 4 Supplement 1:239-239
Publikováno v:
Reumatología Clínica. 12:210-215
Lupus nephritis (LN) is a common and severe complication in patients with lupus. Current therapy is based on immunosuppressive drugs and glucocorticoids. Recently, rituximab has been proposed as an alternative treatment for LN. Rituximab is a monoclo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d12f2689899efac91b6c8cafe47f3fe
https://doi.org/10.1016/j.reuma.2016.01.001
https://doi.org/10.1016/j.reuma.2016.01.001
Publikováno v:
Reumatologia clinica. 12(4)
Lupus nephritis (LN) is a common and severe complication in patients with lupus. Current therapy is based on immunosuppressive drugs and glucocorticoids. Recently, rituximab has been proposed as an alternative treatment for LN. Rituximab is a monoclo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c265651bf1d99e565ac788473b72c33b
https://pubmed.ncbi.nlm.nih.gov/26906063
https://pubmed.ncbi.nlm.nih.gov/26906063